These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28004432)

  • 1. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
    Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin used as prognostic marker of urological tumors.
    Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
    World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
    Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
    Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
    Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
    J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer.
    Kohli M; Fink LM; Spencer HJ; Zent CS
    Blood Coagul Fibrinolysis; 2002 Jan; 13(1):1-5. PubMed ID: 11994561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index.
    Stephan C; Lein M; Matalon J; Kilic E; Zhao Z; Busch J; Jung K
    J Urol; 2016 Sep; 196(3):709-14. PubMed ID: 26976204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between coagulation function, tumor stage and metastasis in patients with renal cell carcinoma: a retrospective study.
    Xiao B; Ma LL; Zhang SD; Xiao CL; Lu J; Hong K; Liao HY
    Chin Med J (Engl); 2011 Apr; 124(8):1205-8. PubMed ID: 21542997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
    Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
    Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Underwent Transrectal Ultrasound-Guided Prostate Biopsy.
    Wang FM; Xing NZ
    Dis Markers; 2021; 2021():8899994. PubMed ID: 33532007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum concentration of type IV collagen in urological cancer--comparison with serum concentration of laminin].
    Isobe H; Iwata S; Fujime M; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):457-62. PubMed ID: 8515631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary tissue factor levels in patients with bladder and prostate cancer.
    Lwaleed BA; Francis JL; Chisholm M
    Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
    Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
    In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte tissue factor levels in cancer patients.
    Lwaleed BA; Francis JL; Chisholm M
    Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
    Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
    Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.
    Gorin MA; Verdone JE; van der Toom E; Bivalacqua TJ; Allaf ME; Pienta KJ
    Nat Rev Urol; 2017 Feb; 14(2):90-97. PubMed ID: 27872478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
    Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
    Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.